Next Article in Journal
Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma
Next Article in Special Issue
Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α
Previous Article in Journal
Mutant C. elegans p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell Death
Previous Article in Special Issue
Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
 
 
Perspective

Article Versions Notes

Cancers 2022, 14(19), 4931; https://doi.org/10.3390/cancers14194931
Action Date Notes Link
article pdf uploaded. 8 October 2022 13:34 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4931/pdf-vor
article xml file uploaded 10 October 2022 08:12 CEST Original file -
article xml uploaded. 10 October 2022 08:12 CEST Update https://www.mdpi.com/2072-6694/14/19/4931/xml
article pdf uploaded. 10 October 2022 08:12 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4931/pdf
article html file updated 10 October 2022 08:13 CEST Original file -
article html file updated 10 October 2022 10:11 CEST Update -
article html file updated 28 February 2023 17:07 CET Update -
article html file updated 1 March 2023 20:10 CET Update https://www.mdpi.com/2072-6694/14/19/4931/html
Back to TopTop